Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ODYSSEY: Tradipitant in Severe or Critical COVID-19
NCT04326426Phase 3Enrolling by invitation
- Sponsor
- Vanda Pharmaceuticals Inc.
- Start
- Apr 2020
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tradipitant in coronavirus disease 2019 (COVID-19), sponsored by Vanda Pharmaceuticals Inc.. Started Apr 2020; status: enrolling by invitation.
02
Drugs
tradipitant
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04326426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04326426.